Study of care for long COVID symptoms in adults
Treatments studied
Part of Brain & nervous system, Immune system & allergy, Lungs & breathing clinical trials.
This study follows people who enter a specialized care pathway for long COVID (post-COVID syndrome) to better understand symptoms, needs, and outcomes. It may help improve how multidisciplinary care is organized for long COVID over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You joined the Epsilon care pathway since it started in February 2022.
- Your COVID illness included documented COVID pneumonia (confirmed in records).
- You have ongoing symptoms: severe symptoms after 4 weeks, or complex/disabling symptoms lasting more than 3 months.
- Your symptoms led to referral to the Epsilon care team either from city medicine or after a hospital stay for oxygen therapy for at least 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with lasting or complex COVID-19 symptoms who are already in a specialized care program. It aims to better understand and improve recovery after COVID.
This study compares the blood of people with ongoing long COVID symptoms to healthy people, to look for differences in immune signals and gut bacteria. It could help find better ways to diagnose or treat long COVID.
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
This study builds a health registry to learn how long COVID affects children, teens, and adults over time. It may help by improving understanding of symptoms and care, even if it does not test a new drug.
This study looks at people with lingering post-COVID symptoms, especially breathing and lung-related findings, using home monitoring and medical tests. It may help researchers understand what’s driving ongoing symptoms and identify patterns that could guide better care.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
Hear when a new Post COVID Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.